Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients
Sung‐Nan Pei(Chang Gung University), Ching‐Yuan Kuo(Chang Gung University), Tsung‐Hui Hu(National Sun Yat-sen University), Chuan–Mo Lee(Chang Gung University), Ming‐Chung Wang(Chang Gung University), Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Ming‐Chun Ma(Chang Gung University)
Cited by 211
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
|Gastroenterology|2007|232
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|221
Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan
|World Journal of Gastroenterology|2006|217